← Back to Search

Text-Based Screening for Postpartum Mental Health & Substance Use Disorders

N/A
Waitlist Available
Led By Constance Guille, MD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline substance use to follow-up substance use during the postpartum year, approximately over 21 months.
Awards & highlights

Study Summary

This trial compares text-based mental health and substance use screening with in-person screening for pregnant and postpartum people aged 18-45. Participating involves online questionnaires. Eligibility: pregnant, entering prenatal care at MUSC OB clinic.

Who is the study for?
This trial is for pregnant individuals aged 18-45 who are receiving prenatal care at MUSC's OB clinics and have attended a prenatal appointment there. It aims to help those facing postpartum depression, anxiety, or substance use disorders.Check my eligibility
What is being tested?
The study compares a text message-based program called LTWP with standard in-person screening for mental health and substance use issues. It looks at how well participants start and stick with treatment programs after being referred.See study design
What are the potential side effects?
Since the intervention involves screening and referral through text messaging rather than medication or medical procedures, no direct side effects are expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline substance use to follow-up substance use during the postpartum year, approximately over 21 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline substance use to follow-up substance use during the postpartum year, approximately over 21 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Retention in Treatment
Change in Treatment Attendance
Secondary outcome measures
Change in Maternal Functioning and Wellbeing
Change in Substance Use
Change in depressive symptoms

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Listening to Women & Pregnant & Postpartum People (LTWP)Experimental Treatment1 Intervention
This group will receive text-message-based SBIRT with phone-based assessment and referral to treatment. The SBIRT is a survey with 9 questions related to depression, anxiety, substance abuse (alcohol, cigarettes, and other drugs including prescription medication), and domestic violence.
Group II: Screening Brief Intervention & Referral to Treatment (SBIRT)Active Control1 Intervention
This group will receive in-person screening and referral to treatment assessment.

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
551 Previous Clinical Trials
29,988,014 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,385,192 Total Patients Enrolled
Constance Guille, MDPrincipal InvestigatorMedical University of South Carolina
1 Previous Clinical Trials
442 Total Patients Enrolled

Media Library

Listening to Women & Postpartum People Clinical Trial Eligibility Overview. Trial Name: NCT05764213 — N/A
Substance Use Disorder Research Study Groups: Screening Brief Intervention & Referral to Treatment (SBIRT), Listening to Women & Pregnant & Postpartum People (LTWP)
Substance Use Disorder Clinical Trial 2023: Listening to Women & Postpartum People Highlights & Side Effects. Trial Name: NCT05764213 — N/A
Listening to Women & Postpartum People 2023 Treatment Timeline for Medical Study. Trial Name: NCT05764213 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there current opportunities for enrolment in this clinical trial?

"Clinicaltrials.gov displays that this medical investigation is no longer recruiting, having been initially posted on April 3rd 2023 then last updated by the same date. Though not actively searching for participants at present, 503 other trials are presently seeking patients."

Answered by AI

What criteria must potential participants meet to be eligible for this trial?

"The criteria for admission into this trial necessitates that participants have postpartum depression and are between 18-45 years old. Up to 9444 people can join the program."

Answered by AI

Does the research protocol allow for individuals aged 70 and over to participate?

"The age requirement for this medical trial is that all participants must be 18 years or older, but not exceed 45."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Improving Maternal Mental Health & SUD Screening and Treatment
Constance Guille 2023. "Improving Maternal Mental Health & SUD Screening and Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05764213.
~5247 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top